WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells
Cancer Chemotherapy and Pharmacology · 2025-12 · 95 (1)
DOI: 10.1007/s00280-024-04731-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 17.01.2025. Verfasst von João Marcos Oliveira-Silva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Human Genetics Laboratory, Institute of Natural Sciences, Federal University of Alfenas (UNIFAL-MG), Alfenas, MG, 37130-001, Brazil. Hauptthemen laut MEDLINE: Histone Deacetylase 6, Melanoma, Histone Deacetylase Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Human Genetics Laboratory, Institute of Natural Sciences, Federal University of Alfenas (UNIFAL-MG), Alfenas, MG, 37130-001, Brazil.
- Postgraduate Program in Biosciences Applied to Health (PPGB), Federal University of Alfenas (UNIFAL-MG), Alfenas, MG, 37130-001, Brazil.
- Institute of Biomedical Sciences, Federal University of Alfenas (UNIFAL-MG), Alfenas, MG, 37130-001, Brazil.
- Human Genetics Laboratory, Institute of Natural Sciences, Federal University of Alfenas (UNIFAL-MG), Alfenas, MG, 37130-001, Brazil. mauricio.castro@unifal-mg.edu.br.
- Postgraduate Program in Biosciences Applied to Health (PPGB), Federal University of Alfenas (UNIFAL-MG), Alfenas, MG, 37130-001, Brazil. mauricio.castro@unifal-mg.edu.br.
ORCID-Profile: João Marcos Oliveira-Silva, Carlos Vinicius Expedito de Souza, Alexandre Ferro Aissa, Graziela Domingues de Almeida Lima, Marisa Ionta, Angel Mauricio Castro-Gamero
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Zitieren
APA
Oliveira-Silva, J. M., Oliveira, L. S., Chiminazo, C. B., Fonseca, R., de Souza, C. V. E., Aissa, A. F., de Almeida Lima, G. D., Ionta, M., & Castro-Gamero, A. M. (2025). WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells. Cancer Chemotherapy and Pharmacology, 95(1). https://doi.org/10.1007/s00280-024-04731-y
Vancouver
Oliveira-Silva JM, Oliveira LS, Chiminazo CB, Fonseca R, de Souza CVE, Aissa AF, et al. WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells. Cancer Chemotherapy and Pharmacology. 2025;95(1). doi:10.1007/s00280-024-04731-y
BibTeX
@article{OliveiraSilva2025,
author = {Oliveira-Silva, João Marcos and Oliveira, Leilane Sales and Chiminazo, Carolina Berraut and Fonseca, Rafael and de Souza, Carlos Vinicius Expedito and Aissa, Alexandre Ferro and de Almeida Lima, Graziela Domingues and Ionta, Marisa and Castro-Gamero, Angel Mauricio},
title = {WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2025},
volume = {95},
number = {1},
doi = {10.1007/s00280-024-04731-y}
}
EUVIMED